{
    "clinical_study": {
        "@rank": "51933", 
        "acronym": "TIM-HF II", 
        "arm_group": [
            {
                "arm_group_label": "Remote Patient Management", 
                "arm_group_type": "Experimental", 
                "description": "intervention group"
            }, 
            {
                "arm_group_label": "Usual Care", 
                "arm_group_type": "Active Comparator", 
                "description": "control group"
            }
        ], 
        "brief_summary": {
            "textblock": "Superiority of additional Remote Patient Management (RPM) in patients with chronic heart\n      failure (CHF) in comparison to usual care in terms of, e.g.:\n\n        -  days lost due to unplanned cardiovascular hospitalization or death\n\n        -  all-cause mortality\n\n        -  cardiovascular mortality\n\n        -  quality of life"
        }, 
        "brief_title": "Telemedical Interventional Management in Heart Failure II", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "The clinical trial assesses 1,500 patients over a period of 12 months each (2013 until\n      2015). All participants will continue to receive usual care from their general practitioner\n      and specialist. All patients will be examined at the beginning of the study and will undergo\n      a check-up every 3 months. 750 of the patients will be randomly allocated to receive devices\n      for Remote Patient Management (RPM) which will measure various parameters on a daily basis\n      (e.g. weight, blood pressure, heart rate). The devices are mobile and can be used at home or\n      elsewhere."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  chronic heart failure New York Heart Association (NYHA) class II or III\n\n          -  echocardiographically determined left ventricular ejection fraction (LVEF) \u226445% or\n             >45% + minimum 1 diuretic in permanent medicinal therapy\n\n          -  hospitalization due to decompensated HF within the last 12months before randomization\n\n          -  informed consent\n\n        Exclusion Criteria:\n\n          -  hospitalization within the last 7 days before randomization\n\n          -  implanted cardiac assist system\n\n          -  acute coronary syndrome within the last 7 days before randomization\n\n          -  high urgent listed for heart transplantation (HTx)\n\n          -  planned revascularization, Transcatheter Aortic Valve Implantation (TAVI), MitraClip\n             and/or Cardiac Resynchronization Therapy (CRT)-implantation within the last 3 months\n             before randomization\n\n          -  revascularization and/or CRT-implantation within the last 3 months before\n             randomization\n\n          -  known alcohol or drug abuse\n\n          -  terminal renal insufficiency with hemodialysis\n\n          -  impairment or unwillingness  to use the telemonitoring equipment (e.g. dementia,\n             impaired self-determination, lacking ability to communicate)\n\n          -  existence of any disease reducing life expectancy to less than 1 year\n\n          -  age <18 years\n\n          -  pregnancy\n\n          -  participation in other treatment studies or remote patient management programmes\n             (register studies possible)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01878630", 
            "org_study_id": "13KQ0904B"
        }, 
        "intervention": [
            {
                "arm_group_label": "Remote Patient Management", 
                "description": "Guideline-based care in heart failure including at least 5 scheduled doctor's visits within 12 months (GP and specialist) plus devices for Remote Patient Management at patient site for daily monitoring of ECG, weight, blood pressure, self-report of health status:\nweighing scale (Seca 861 with bluetooth, seca gmbh & co. kg.)\nblood pressure device (UA767PBT with bluetooth, A&D Ltd.)\nECG-eventrecorder (PhysioMem\u00ae PM 1000, getemed Medizin- und Informationstechnik AG)\npatient-communication platform (Physio-Gate\u00ae PG 1000, getemed Medizin- und Informationstechnik AG)\nhelp call device (DORO Easy 510/ Doro HandlePlus 334gsm, doro AB)\nat center site:\n- electronic patient record (eHealth connect 2.0, T-Systems International)", 
                "intervention_name": "Remote Patient Management", 
                "intervention_type": "Device", 
                "other_name": "R&D project \"Fontane\""
            }, 
            {
                "arm_group_label": "Usual Care", 
                "description": "Guideline-based care in heart failure including at least 5 scheduled doctor's visits within 12 months (GP and specialist)", 
                "intervention_name": "Usual Care", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic Heart Failure", 
            "CHF"
        ], 
        "lastchanged_date": "April 29, 2014", 
        "link": [
            {
                "description": "affiliation website", 
                "url": "http://telemedizin.charite.de/en/"
            }, 
            {
                "description": "study website, only in German", 
                "url": "http://www.fontane-studie.de"
            }, 
            {
                "description": "project website, only in German", 
                "url": "http://www.gesundheitsregion-fontane.de"
            }
        ], 
        "location": {
            "contact": {
                "email": "friedrich.koehler@charite.de", 
                "last_name": "Friedrich Koehler, Prof. Dr.", 
                "phone": "+49 30 450 514 184"
            }, 
            "facility": {
                "address": {
                    "city": "Berlin", 
                    "country": "Germany", 
                    "zip": "10117"
                }, 
                "name": "Charit\u00e9 - Universitaetsmedizin Berlin"
            }, 
            "investigator": {
                "last_name": "Friedrich Koehler, Prof. Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "friedrich.koehler@charite.de", 
            "last_name": "Friedrich Koehler, Prof. Dr.", 
            "phone": "+49 30 450 514 184"
        }, 
        "overall_official": {
            "affiliation": "Charit\u00e9 - Universitaetsmedizin Berlin", 
            "last_name": "Friedrich Koehler, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Days lost due to unplanned cardiovascular hospitalization or death.", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "reference": [
            {
                "PMID": "21982700", 
                "citation": "Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, B\u00f6hm M, de Brouwer S, Perrin E, Baumann G, Gelbrich G, Boll H, Honold M, Koehler K, Kirwan BA, Anker SD. Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol. 2012 Nov 29;161(3):143-50. doi: 10.1016/j.ijcard.2011.09.007. Epub 2011 Oct 8."
            }, 
            {
                "PMID": "21444883", 
                "citation": "Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, B\u00f6hm M, Boll H, Baumann G, Honold M, Koehler K, Gelbrich G, Kirwan BA, Anker SD; Telemedical Interventional Monitoring in Heart Failure Investigators. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011 May 3;123(17):1873-80. Epub 2011 Mar 28."
            }, 
            {
                "PMID": "21856487", 
                "citation": "Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet. 2011 Aug 20;378(9792):731-9. doi: 10.1016/S0140-6736(11)61229-4. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01878630"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Charite University, Berlin, Germany", 
            "investigator_full_name": "Friedrich Koehler", 
            "investigator_title": "Prof. Dr. Friedrich Koehler, MD, Senior Physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "all-cause mortality (time-to-event)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "cardiovascular mortality (time-to-event)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "days lost regarding 12month follow-up due to unplanned cardiovascular hospitalizations", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "days lost regarding 12month follow-up due to HF-hospitalization; number of unplanned cardiovascular hospitalizations (adjusted to death)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "number of unplanned HF-hospitalizations (adjusted to death)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "number of unplanned cardiovascular re-admissions within 30 days after discharge from unplanned cardiovascular hospitalization", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Quality of life measured by Minnesota Living with Hear Failure Questionnaire; EQ-5D-3L, depression by PHQ-9 and self-care behaviour by EHFScBS-9", 
                "measure": "quality of life, depression and self-care behaviour", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "cost-utility analysis (QALY-analysis)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Charite University, Berlin, Germany", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "German Federal Ministry of Education and Research", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Leipzig", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Charite University, Berlin, Germany", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}